Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

A new treatment for gonorrhea shows promise, which is welcome news with global rates of the sexually transmitted infection on the rise and antibiotic resistance becoming more prevalent. The oral ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

A new antibiotic has proven as effective as the last remaining recommended treatment for gonorrhea, helping to assuage mounting fears among public health experts about the emergence of drug-resistant ...

No one wants to hear that they’ve contracted a sexually transmitted infection (STI). Having one can mean discomfort, inconvenience, potential embarrassment and often requires putting intimacy on hold ...

Zoliflodacin demonstrated high microbiological cure rates for uncomplicated urogenital gonorrhea, with 90.9% efficacy in the general population. The trial was open-label and had limited representation ...

The term “super gonorrhea” refers to the growing resistance to antibiotic treatments for bacteria that cause gonorrhea. This limits treatment options and can make this sexually transmitted infection ...

Gepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of the phase III EAGLE-1 trial. The ...